ScholarIQanswers from OpenAlex

miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro

PaperCitations, authors & open-access status

miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro is a paper indexed in ScholarIQ from OpenAlex.

How many citations does miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro have?

ScholarIQcitation count

miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro has 3 citations in the OpenAlex counts ScholarIQ stores.

When was miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro published?

ScholarIQyear

miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro has 2024 year in the ScholarIQ index.

What is the open-access status of miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro?

ScholarIQoa status

miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro has closed oa status in the ScholarIQ index.

What is the DOI of miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro?

ScholarIQdoi

The DOI for miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro is on the source record.

What is the PMID of miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro?

ScholarIQpmid

The PMID for miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro is on the source record.

What is the OpenAlex record for miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro?

ScholarIQopenalex

The OpenAlex for miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial